Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
98.10
-0.30 (-0.30%)
Mar 9, 2026, 1:59 PM EDT - Market open
Revolution Medicines Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$114.63
Upside
+16.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $75 → $120 | Buy | Maintains | $75 → $120 | +22.32% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $100 → $144 | Buy | Maintains | $100 → $144 | +46.79% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Maintains $150 → $145 | Strong Buy | Maintains | $150 → $145 | +47.81% | Feb 26, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $92 → $122 | Buy | Maintains | $92 → $122 | +24.36% | Feb 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 → $150 | Buy | Maintains | $75 → $150 | +52.91% | Jan 27, 2026 |
| Stifel | Stifel | Strong Buy Maintains $85 → $170 | Strong Buy | Maintains | $85 → $170 | +73.29% | Jan 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $77 → $140 | Buy | Maintains | $77 → $140 | +42.71% | Jan 21, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $92 → $160 | Strong Buy | Maintains | $92 → $160 | +63.10% | Jan 20, 2026 |
| Mizuho | Mizuho | Buy Maintains $90 → $143 | Buy | Maintains | $90 → $143 | +45.77% | Jan 13, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $75 | Buy | Initiates | $75 | -23.55% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $71 → $82 | Buy | Maintains | $71 → $82 | -16.41% | Nov 6, 2025 |
| Wedbush | Wedbush | Buy Maintains $77 → $80 | Buy | Maintains | $77 → $80 | -18.45% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $66 → $72 | Strong Buy | Maintains | $66 → $72 | -26.61% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $73 | Strong Buy | Maintains | $72 → $73 | -25.59% | Nov 6, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $77 | Buy | Initiates | $77 | -21.51% | Nov 3, 2025 |
| Mizuho | Mizuho | Buy Initiates $90 | Buy | Initiates | $90 | -8.26% | Oct 21, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.